Search Within

Philippe Joubert

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Pathology and Laboratory Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Tow Center for Developmental Oncology (TCDO) (5)
  5. Department of Medicine (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Marc Ladanyi (5)
  2. Alexander Drilon (3)
  3. Lu Wang (3)
  4. Naiyer Rizvi (3)
  5. Adnan Hasanovic (2)
  6. Gregory Riely (2)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2013 (3)
Publications
  1. Modern Pathology (2)
  2. Journal of Clinical Oncology (1)
  3. Journal of Molecular Diagnostics (1)
  4. Journal of Thoracic Oncology (1)
Publishers
  1. Nature Research (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations
    Journal Article

    Rekhtman, N.; Pietanza, C. M.; Sabari, J.; Montecalvo, J.; Wang, H.; Habeeb, O.; Kadota, K.; Adusumilli, P.; Rudin, C. M.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1-ATF1 fusions
    Meeting Abstract

    Desmeules, P.; Joubert, P.; Al-Ahmadie, H.; Fletcher, C. D. M.; Delair, D.; Rekhtman, N.; Ladanyi, M.; Travis, W.; Antonescu, C. R.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The prevalence of RET and ROS1 gene rearrangements in advanced lung adenocarcinomas pan-negative for other known drivers as revealed by FISH analysis
    Meeting Abstract

    Wang, L.; Islamdoust, N.; Drilon, A. E.; Rizvi, N.; Joubert, P.; Hasanovic, A.; Wynne, M.; Intrieri, J.; Jhanwar, S. C.; Ladanyi, M.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save